The global needle-free injectors market size was estimated to be US$ 5.7 billion in 2020 and is expected to reach US$ 27.5 billion by 2032 at a CAGR of 15.5%.
Some of the major factors driving this market's growth are the rising prevalence of chronic disease, rising incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, and rising demand for self-injection devices. However, the high development cost of needle-free injection systems compared to traditional needle injection may stifle market growth throughout the forecast period.
The analysis divides the market into categories based on product, technology, type, delivery location, applications, end user, and geography. Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors, and vibration-based needle-free injectors are the four types of needle-free injectors available on the market. Jet-based needle-free injectors are expected to grow at the quickest rate throughout the forecast period due to their benefits over other injector technologies.
Rising demand for self-injection devices, advanced medical infrastructure, a growing geriatric population, rising prevalence of chronic and infectious diseases, lack of reusability of traditional needles, rising healthcare expenditures, and the rising need for vaccination are all driving the needle-free injectors market. Pharmaceutical companies are concentrating on developing innovative, safe, and pain-free injectors to fulfil the rising demand for self-injection devices. As a consequence, the introduction of new high-quality products into the market is expected to propel the needle-free injectors market forward during the study period.
The needle-free injectors market is segmented based on applications, load, technology, end-users, delivery location, usage, and region. The applications area includes drug delivery, immunizations, cosmetics, and other uses. The pharmaceutical delivery sector is expected to dominate this market in the near future due to the rising prevalence of chronic diseases and the ageing population. Based on the load, the market is segmented into liquid injections, powder injections, and projectile injections. The liquid sector is projected to maintain a significant market share in the coming days due to its swift administration and flexibility. Spring-loaded jet injectors, battery-powered jet injectors, and gas-powered jet injectors are the three technological segments that make up the market. The market includes hospitals, veterinary hospitals, specialized clinics, home care settings, and other end-users. The market is classified into intradermal injectors, intramuscular injectors, and subcutaneous injectors based on distribution site.
Costly product development, strict government regulatory restrictions related to injectors, and a lack of worker confidence, on the other hand, are projected to hinder market acceptability in the coming years. A needle-free injection technique uses Lorentz force, shock waves, pressure, or electrophoresis force to deliver drugs through the skin. Needle Free Injection Systems are preferred over hypodermic needles because, unlike syringe systems, they may be used several times without risk of infection transmission. They also assist in the avoidance of needlestick injuries and pain during the administration of medications. An increase in the prevalence of needle stick injuries and needle phobia among the global population is estimated to boost the market over the forecast period. However, due to low levels of acceptability and awareness in emerging nations, the Needle Free Injection Systems industry's growth prospects are projected to be constrained.
Global Needle-free Injectors Market - Share Analysis, by Geography (2021)
The report titled “Global Needle-free Injectors Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” offers market estimates for a period 2022 to 2032, wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in Global Needle-free Injectors Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
Self-injection has psychological benefits over professional administration, such as increased self-esteem. Regular injections in a clinic or hospital are no longer required, which saves money for both the patient and the healthcare system. Self-injection devices' cost-effectiveness has been a major driver of the needle-free injection market's growth. Self-injections are used to help individuals recover from chronic autoimmune ailments including rheumatoid arthritis and cancer, which has supported the industry's growth. Over the forecast period, these factors will force the market ahead.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Needle-free Injectors Market. Further, market share of prominent companies in the Global Needle-free Injectors Market would also be estimated. The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the Global Needle-free Injectors Market companies.
The Global Needle-free Injectors Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the relevant business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Global Needle-free Injectors Market.
The needle-free injection system market is dominated by a number of international and domestic firms. Players in this market provide a variety of detectors in distinct subsegments. Endo International plc (United Kingdom), PharmaJet (United States), Bioject Medical Technologies Inc. (United States), Medical International Technology, Inc. (United States), INJEX Pharma AG (Germany), National Medical Products Inc. (United States), Valeritas, Inc. (United States), European Pharma Group (Netherlands), PenJet Corporation (United States), Crossject SA (United Kingdom), European Pharma Group (Netherlands), Pen (France).
Segmentation:
By Product
By Technology
By Usability
By type of Medication
By Site of Delivery
By Application
By End User
By Geography
The global needle-free injectors market size was estimated to be US$ 5.7 billion in 2020
The needle-free injector market is expected to grow at a CAGR of 15.5% between 2022 and 2032.
Endo International plc (United Kingdom), PharmaJet (United States), Bioject Medical Technologies Inc. (United States), Medical International Technology, Inc. (United States), INJEX Pharma AG (Germany), National Medical Products Inc. (United States), Valeritas, Inc. (United States), European Pharma Group (Netherlands), PenJet Corporation (United States), Crossject SA (United Kingdom), European Pharma Group (Netherlands), Pen (France)
North America is the prominent geography of needle-free injectors market
The needle-free injectors market is being driven by rising demand for self-injection devices, advanced medical infrastructure, a growing geriatric population, rising prevalence of chronic and infectious diseases, lack of reusability of traditional needles, rising healthcare expenditures, and the rising need for vaccination.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved